US Stock MarketDetailed Quotes

MREO Mereo BioPharma

Watchlist
  • 3.8100
  • +0.4200+12.39%
Close Dec 24 13:00 ET
591.10MMarket Cap-12.70P/E (TTM)

Mereo BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-382.78%-7.52M
-1.93%-7.9M
13.59%-7.99M
56.72%-21.13M
-6.79M
2.66M
-7.75M
-9.25M
-590.46%-48.82M
81.69%-7.07M
Net income from continuing operations
-129.69%-15M
-600.00%-12.26M
25.88%-8.95M
30.21%-29.47M
---9.11M
---6.53M
---1.75M
---12.08M
-319.66%-42.22M
108.47%19.22M
Operating gains losses
363.00%6.48M
-95.80%38K
-124.81%-165K
117.50%2.1M
--3M
---2.47M
--905K
--665K
77.30%-12.01M
-131.68%-52.9M
Depreciation and amortization
0.00%282K
-5.17%257K
21.15%275K
19.35%1.06M
--281K
--282K
--271K
--227K
2.60%889K
-60.24%866.47K
Other non cash items
-46.58%359K
-65.97%309K
537.14%306K
-12.51%1.84M
--330K
--672K
--908K
---70K
-88.38%2.1M
154.15%18.1M
Change In working capital
-115.06%-1.38M
118.40%1.66M
-505.93%-1.51M
32.27%-1.59M
---2.1M
--9.17M
---9.03M
--371K
5.55%-2.35M
46.42%-2.49M
-Change in receivables
-113.36%-226K
74.04%-370K
4.41%-477K
113.15%456K
--688K
--1.69M
---1.43M
---499K
-336.14%-3.47M
-513.69%-794.94K
-Change in prepaid assets
-89.79%870K
86.22%-1.3M
-41.10%1.94M
-5.64%502K
---1.92M
--8.53M
---9.4M
--3.29M
--532K
----
-Change in payables and accrued expense
-105.88%-1.86M
79.60%3.49M
-23.01%-2.81M
-235.04%-1.97M
---726K
---902K
--1.94M
---2.29M
186.19%1.46M
64.97%-1.7M
-Change in other current liabilities
-13.51%-168K
-11.11%-160K
-14.71%-156K
34.17%-578K
---150K
---148K
---144K
---136K
---878K
----
Cash from discontinued investing activities
Operating cash flow
-382.78%-7.52M
-1.93%-7.9M
13.59%-7.99M
56.72%-21.13M
---6.79M
--2.66M
---7.75M
---9.25M
-590.46%-48.82M
81.69%-7.07M
Investing cash flow
Cash flow from continuing investing activities
0
1K
-67.06%-700K
-121.09%-419K
0
0
0
-419K
449.70%1.99M
-127.89%-568.2K
Net PPE purchase and sale
----
----
----
--0
----
----
----
----
375.19%1.99M
-3,211.39%-722.06K
Net intangibles purchase and sale
--0
--1K
-67.06%-700K
---419K
--0
--0
--0
---419K
--0
-93.85%152.51K
Net business purchase and sale
----
----
----
----
----
----
----
----
----
--0
Cash from discontinued investing activities
Investing cash flow
--0
--1K
-67.06%-700K
-121.09%-419K
--0
--0
--0
---419K
449.70%1.99M
-127.89%-568.2K
Financing cash flow
Cash flow from continuing financing activities
-107.51%-594K
3,886.50%7.97M
0
7.91M
-99.81%200K
121.38%104.8M
Net issuance payments of debt
----
----
----
---3.19M
--0
----
----
----
----
-103.05%-933.95K
Net common stock issuance
--0
----
----
--11.61M
--0
--11.61M
----
----
--0
286.23%105.99M
Cash dividends paid
----
----
----
----
----
----
----
----
----
--0
Proceeds from stock option exercised by employees
----
----
----
----
----
----
----
----
----
--62.08K
Net other financing activities
-16.24%-594K
----
----
-322.00%-444K
--0
---511K
----
----
163.33%200K
95.35%-315.82K
Cash from discontinued financing activities
Financing cash flow
-107.51%-594K
----
----
3,886.50%7.97M
--0
--7.91M
----
----
-99.81%200K
121.38%104.8M
Net cash flow
Beginning cash position
65.07%87.43M
-18.64%48.66M
-15.78%57.42M
-46.48%68.18M
--62.53M
--52.97M
--59.81M
--68.18M
302.21%127.4M
42.18%31.67M
Current changes in cash
-176.79%-8.11M
605.76%38.88M
10.10%-8.69M
70.88%-13.58M
---6.79M
--10.57M
---7.69M
---9.67M
-148.00%-46.63M
803.50%97.16M
Effect of exchange rate changes
220.04%1.2M
-112.65%-107K
-105.41%-70K
122.40%2.82M
--1.68M
---1M
--846K
--1.29M
-700.22%-12.58M
-50.03%-1.57M
End cash Position
28.78%80.52M
65.07%87.43M
-18.64%48.66M
-15.78%57.42M
--57.42M
--62.53M
--52.97M
--59.81M
-46.43%68.18M
297.90%127.27M
Free cash flow
-382.78%-7.52M
-1.92%-7.9M
10.10%-8.69M
55.87%-21.55M
---6.79M
--2.66M
---7.75M
---9.67M
-526.66%-48.83M
79.84%-7.79M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -382.78%-7.52M-1.93%-7.9M13.59%-7.99M56.72%-21.13M-6.79M2.66M-7.75M-9.25M-590.46%-48.82M81.69%-7.07M
Net income from continuing operations -129.69%-15M-600.00%-12.26M25.88%-8.95M30.21%-29.47M---9.11M---6.53M---1.75M---12.08M-319.66%-42.22M108.47%19.22M
Operating gains losses 363.00%6.48M-95.80%38K-124.81%-165K117.50%2.1M--3M---2.47M--905K--665K77.30%-12.01M-131.68%-52.9M
Depreciation and amortization 0.00%282K-5.17%257K21.15%275K19.35%1.06M--281K--282K--271K--227K2.60%889K-60.24%866.47K
Other non cash items -46.58%359K-65.97%309K537.14%306K-12.51%1.84M--330K--672K--908K---70K-88.38%2.1M154.15%18.1M
Change In working capital -115.06%-1.38M118.40%1.66M-505.93%-1.51M32.27%-1.59M---2.1M--9.17M---9.03M--371K5.55%-2.35M46.42%-2.49M
-Change in receivables -113.36%-226K74.04%-370K4.41%-477K113.15%456K--688K--1.69M---1.43M---499K-336.14%-3.47M-513.69%-794.94K
-Change in prepaid assets -89.79%870K86.22%-1.3M-41.10%1.94M-5.64%502K---1.92M--8.53M---9.4M--3.29M--532K----
-Change in payables and accrued expense -105.88%-1.86M79.60%3.49M-23.01%-2.81M-235.04%-1.97M---726K---902K--1.94M---2.29M186.19%1.46M64.97%-1.7M
-Change in other current liabilities -13.51%-168K-11.11%-160K-14.71%-156K34.17%-578K---150K---148K---144K---136K---878K----
Cash from discontinued investing activities
Operating cash flow -382.78%-7.52M-1.93%-7.9M13.59%-7.99M56.72%-21.13M---6.79M--2.66M---7.75M---9.25M-590.46%-48.82M81.69%-7.07M
Investing cash flow
Cash flow from continuing investing activities 01K-67.06%-700K-121.09%-419K000-419K449.70%1.99M-127.89%-568.2K
Net PPE purchase and sale --------------0----------------375.19%1.99M-3,211.39%-722.06K
Net intangibles purchase and sale --0--1K-67.06%-700K---419K--0--0--0---419K--0-93.85%152.51K
Net business purchase and sale --------------------------------------0
Cash from discontinued investing activities
Investing cash flow --0--1K-67.06%-700K-121.09%-419K--0--0--0---419K449.70%1.99M-127.89%-568.2K
Financing cash flow
Cash flow from continuing financing activities -107.51%-594K3,886.50%7.97M07.91M-99.81%200K121.38%104.8M
Net issuance payments of debt ---------------3.19M--0-----------------103.05%-933.95K
Net common stock issuance --0----------11.61M--0--11.61M----------0286.23%105.99M
Cash dividends paid --------------------------------------0
Proceeds from stock option exercised by employees --------------------------------------62.08K
Net other financing activities -16.24%-594K---------322.00%-444K--0---511K--------163.33%200K95.35%-315.82K
Cash from discontinued financing activities
Financing cash flow -107.51%-594K--------3,886.50%7.97M--0--7.91M---------99.81%200K121.38%104.8M
Net cash flow
Beginning cash position 65.07%87.43M-18.64%48.66M-15.78%57.42M-46.48%68.18M--62.53M--52.97M--59.81M--68.18M302.21%127.4M42.18%31.67M
Current changes in cash -176.79%-8.11M605.76%38.88M10.10%-8.69M70.88%-13.58M---6.79M--10.57M---7.69M---9.67M-148.00%-46.63M803.50%97.16M
Effect of exchange rate changes 220.04%1.2M-112.65%-107K-105.41%-70K122.40%2.82M--1.68M---1M--846K--1.29M-700.22%-12.58M-50.03%-1.57M
End cash Position 28.78%80.52M65.07%87.43M-18.64%48.66M-15.78%57.42M--57.42M--62.53M--52.97M--59.81M-46.43%68.18M297.90%127.27M
Free cash flow -382.78%-7.52M-1.92%-7.9M10.10%-8.69M55.87%-21.55M---6.79M--2.66M---7.75M---9.67M-526.66%-48.83M79.84%-7.79M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data

Investment Theme Top Gainers Yesterday
Top Gainers Yesterday
Intraday-2.53%